Page last updated: 2024-09-05

17 alpha-hydroxyprogesterone caproate and dapagliflozin

17 alpha-hydroxyprogesterone caproate has been researched along with dapagliflozin in 1 studies

Compound Research Comparison

Studies
(17 alpha-hydroxyprogesterone caproate)
Trials
(17 alpha-hydroxyprogesterone caproate)
Recent Studies (post-2010)
(17 alpha-hydroxyprogesterone caproate)
Studies
(dapagliflozin)
Trials
(dapagliflozin)
Recent Studies (post-2010) (dapagliflozin)
517882511,4783681,407

Protein Interaction Comparison

ProteinTaxonomy17 alpha-hydroxyprogesterone caproate (IC50)dapagliflozin (IC50)
Sodium/glucose cotransporter 1Homo sapiens (human)1.1661
Sodium/glucose cotransporter 2Homo sapiens (human)0.0022
Sodium/myo-inositol cotransporter 2Homo sapiens (human)0.38
Solute carrier family 5 member 4Homo sapiens (human)0.0014

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies

Other Studies

1 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and dapagliflozin

ArticleYear
Drugs in traffic: the road to approval.
    Nature medicine, 2011, Dec-06, Volume: 17, Issue:12

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Abiraterone Acetate; Adenine; Androstadienes; Antibodies, Monoclonal, Humanized; Anticarcinogenic Agents; Benzhydryl Compounds; Bevacizumab; Drug Approval; Drug Industry; Glucosides; Hydroxyprogesterones; Indans; Morpholines; Natriuretic Peptide, Brain; Organophosphonates; Protein C; Recombinant Proteins; Rivaroxaban; Tenofovir; Thiophenes

2011